X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (362) 362
Publication (42) 42
Newspaper Article (3) 3
Web Resource (3) 3
Book Chapter (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (188) 188
index medicus (145) 145
female (117) 117
adult (106) 106
male (87) 87
middle aged (84) 84
infectious diseases (72) 72
hepatitis c (61) 61
hepatitis (55) 55
aged (49) 49
infections (48) 48
british columbia - epidemiology (47) 47
virus diseases (46) 46
canada (45) 45
adolescent (44) 44
hepatitis c virus (44) 44
microbiology (43) 43
young adult (42) 42
health aspects (41) 41
public health (41) 41
epidemiology (40) 40
immunology (40) 40
infection (40) 40
gastroenterology & hepatology (39) 39
prevalence (38) 38
diagnosis (36) 36
research (36) 36
hiv (35) 35
hepatitis c - epidemiology (34) 34
risk factors (31) 31
human immunodeficiency virus--hiv (30) 30
mortality (30) 30
prevention (30) 30
virology (30) 30
viruses (28) 28
antiviral agents - therapeutic use (27) 27
canada - epidemiology (27) 27
child (27) 27
hepacivirus - genetics (26) 26
hcv (24) 24
influenza (24) 24
risk (24) 24
human papillomavirus (23) 23
surveillance (23) 23
united-states (23) 23
vaccines (23) 23
british columbia (22) 22
digestive system diseases (22) 22
genotype (22) 22
virus (21) 21
abridged index medicus (20) 20
hepatitis c - virology (20) 20
medicine (20) 20
polymerase chain reaction (20) 20
child, preschool (19) 19
hepatitis c - diagnosis (19) 19
medical screening (19) 19
population (19) 19
virus-infection (19) 19
analysis (18) 18
women (18) 18
cervical cancer (17) 17
disease control (17) 17
drugs (17) 17
efficacy (17) 17
infant (17) 17
research article (17) 17
sensitivity and specificity (17) 17
age (16) 16
drug use (16) 16
incidence (16) 16
interferon (16) 16
retrospective studies (16) 16
rna (16) 16
cohort studies (15) 15
diseases of the digestive system. gastroenterology (15) 15
influenza, human - virology (15) 15
public, environmental & occupational health (15) 15
treatment outcome (15) 15
care and treatment (14) 14
disease (14) 14
disease transmission (14) 14
immunization (14) 14
impact (14) 14
influenza, human - epidemiology (14) 14
people (14) 14
phylogeny (14) 14
prospective studies (14) 14
transmission (14) 14
cirrhosis (13) 13
follow-up (13) 13
hepatitis c - complications (13) 13
infectious and parasitic diseases (13) 13
pregnancy (13) 13
sentinel surveillance (13) 13
time factors (13) 13
vaccine effectiveness (13) 13
acquired immune deficiency syndrome--aids (12) 12
age factors (12) 12
antibodies, viral - blood (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 05/2013, Volume 309, Issue 17, pp. 1793 - 1802
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, p. e92153
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, p. e87872
Background: There has been renewed call for the global expansion of highly active antiretroviral therapy (HAART) under the framework of HIV treatment as... 
RNA | RECOMMENDATIONS | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | HOMOSEXUAL-MEN | SEX | RISK | INJECTING DRUG-USERS | INFECTION | EXPANDING ACCESS | PROSPECTIVE COHORT | HIV Infections - prevention & control | Prevalence | CD4-Positive T-Lymphocytes - cytology | Humans | Drug Resistance, Viral | Acquired Immunodeficiency Syndrome - prevention & control | Treatment Outcome | Communicable Disease Control | Acquired Immunodeficiency Syndrome - drug therapy | Disease Progression | Viral Load | Incidence | Canada | Regression Analysis | Antiretroviral Therapy, Highly Active - utilization | Acquired Immunodeficiency Syndrome - mortality | HIV Infections - drug therapy | HIV Infections - mortality | Poisson Distribution | Registries | Antiretroviral Therapy, Highly Active - methods | Longitudinal Studies | Prevention | Highly active antiretroviral therapy | AIDS treatment | Analysis | Mortality | Drug resistance | HIV (Viruses) | Health aspects | Sustainable development | Patient compliance | Morbidity | Drugs | Epidemics | Health sciences | Therapy | Laboratories | Personal health | Medical diagnosis | Regression models | Consolidation | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Sustainability | Leadership training | Human immunodeficiency virus--HIV | Load resistance | Population | Poisson density functions | Drug therapy | Expansion | Public health | Antiretroviral drugs | Statistical analysis | Regression analysis | Disease control | CD4 antigen | Disease prevention | Medicine | Disease transmission | Medical tests | Cost analysis | Methods | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 12/2017, Volume 216, Issue 12, pp. 1487 - 1500
Vaccine effectiveness estimates for 2015–2016 seasonal influenza vaccine are reported from Canada. Findings suggest that agent-host and immuno-epidemiologic... 
original antigenic sin | vaccine effectiveness | influenza vaccine | hemagglutination inhibition | birth cohort effects | influenza A subtype | repeat vaccination | influenza B lineage | Influenza | sequencing | UNITED-STATES | STRAINS | INFECTIOUS DISEASES | VIRUS | METAANALYSIS | HEMAGGLUTININ | PROTECTION | ANTIBODY | MICROBIOLOGY | IMMUNOLOGY | CHILDREN | SURVEILLANCE | INFECTION | Immunogenicity, Vaccine | Influenza A Virus, H1N1 Subtype - immunology | Influenza Vaccines - administration & dosage | Influenza A Virus, H1N1 Subtype - classification | Age Factors | Humans | Middle Aged | Child, Preschool | Infant | Male | Phylogeny | Hemagglutination Inhibition Tests | Sequence Homology | Young Adult | Influenza B virus - genetics | Canada - epidemiology | Influenza A Virus, H1N1 Subtype - isolation & purification | Aged, 80 and over | Adult | Female | Influenza, Human - virology | Influenza B virus - immunology | Child | Influenza A Virus, H1N1 Subtype - genetics | Influenza B virus - classification | Antigenic Variation | Immunization - methods | Influenza B virus - isolation & purification | Influenza, Human - epidemiology | Treatment Outcome | Sequence Analysis, DNA | Antigens, Viral - immunology | Influenza Vaccines - immunology | Aged | Influenza, Human - prevention & control | Cluster Analysis | Influenza vaccines | Epidemics | Canada | Care and treatment | Usage | Analysis | Antigenic determinants | Major and Brief Reports
Journal Article
Journal Article
CMAJ, ISSN 0820-3946, 06/2017, Volume 189, Issue 25, pp. E869 - E869
Yoshida et al criticize the new recommendations by the Canadian Task Force on Preventive Health Care for screening for hepatitis C virus (HCV) infection, which... 
MEDICINE, GENERAL & INTERNAL | HIV Infections | Hepacivirus | Humans | Hepatitis B - virology | Hepatitis C - virology | Infection | Liver cancer | Task forces | Diagnosis | Pharmaceutical industry | Medical screening | Hepatitis C virus | Health aspects | Hepatitis | Costs | Infections | Preventive medicine | Medical diagnosis | Quality of life | Letters
Journal Article
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 7/2014, Volume 210, Issue 1, pp. 126 - 137
Background. We estimate vaccine effectiveness (VE) against both influenza A/subtypes and B/lineages in Canada for the 2011-2012 trivalent inactivated influenza... 
Influenza vaccines | Viral vaccines | Influenza A virus | Comorbidity | Sentinel surveillance | Vaccine components | Specimens | Viruses | Inactivated vaccines | H3N2 subtype influenza A virus | Influenza A subtype | Influenza B lineage | Influenza | Vaccine effectiveness | Vaccines and immunisation | Trivalent influenza vaccine | influenza | INFECTIOUS DISEASES | NETWORK | vaccines and immunisation | VIRUS | CANADA | influenza A subtype | EFFICACY | trivalent influenza vaccine | PERSISTENCE | ANTIBODY | MICROBIOLOGY | sentinel surveillance | IMMUNOLOGY | vaccine effectiveness | influenza B lineage | SENTINEL SURVEILLANCE SYSTEM | PANDEMIC H1N1 VACCINE | Influenza Vaccines - administration & dosage | Humans | Influenza A virus - genetics | Middle Aged | Child, Preschool | Molecular Sequence Data | Antigens, Viral - genetics | Infant | Male | Hemagglutinin Glycoproteins, Influenza Virus - immunology | Case-Control Studies | Hemagglutinin Glycoproteins, Influenza Virus - genetics | Hemagglutination Inhibition Tests | Young Adult | Influenza B virus - genetics | Vaccination - methods | Canada - epidemiology | Aged, 80 and over | Adult | Female | Influenza A virus - immunology | Influenza, Human - virology | Influenza B virus - immunology | Child | Influenza B virus - classification | Influenza B virus - isolation & purification | Influenza, Human - epidemiology | Treatment Outcome | Influenza A virus - isolation & purification | Sequence Analysis, DNA | Antigens, Viral - immunology | Influenza Vaccines - immunology | Adolescent | Aged | Influenza A virus - classification | Influenza, Human - prevention & control | Influenza, Human - immunology | Care and treatment | Analysis | Research | Health aspects | Sentinel health events
Journal Article
Journal Article